We are live on ! Find out more
Belvedere Trading

Belvedere Trading Portfolio holdings

AUM $87.6B
1-Year Est. Return 131.08%
This Fund
S&P 500
This Quarter Est. Return
+3.34%
1 Year Est. Return
+131.08%
3 Year Est. Return
+497.29%
5 Year Est. Return
+787.25%
10 Year Est. Return
AUM
$3.82B
AUM Growth
+$2.48B
Cap. Flow
+$2.44B
Cap. Flow %
63.89%
Top 10 Hldgs %
92.79%
Holding
683
New
348
Increased
67
Reduced
55
Closed
206

Sector Composition

Rank Sector Weight
1 Technology 4.25%
2 Consumer Discretionary 0.64%
3 Healthcare 0.37%
4 Industrials 0.21%
5 Financials 0.14%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DNMR
326
CALL
DELISTED
Danimer Scientific, Inc.
DNMR
$118K ﹤0.01%
220
+122
+124% +$89.7K
ONCT
327
CALL
DELISTED
Oncternal Therapeutics, Inc. Common Stock
ONCT
$118K ﹤0.01%
+1,555
New +$129K
CCL icon
328
Carnival Corporation Ltd
CCL
$38.1B
$115K ﹤0.01%
4,962
+1,880
+61% +$43.7K
BLU
329
PUT
DELISTED
BELLUS Health Inc.
BLU
$114K ﹤0.01%
+18,200
New +$69K
SIBN icon
330
CALL
SI-BONE Inc
SIBN
$788M
$113K ﹤0.01%
+5,200
New +$132K
HMLP
331
DELISTED
HOEGH LNG PARTNERS LP
HMLP
$113K ﹤0.01%
+20,992
New +$176K
SRTA
332
PUT
Strata Critical Medical Inc
SRTA
$434M
$112K ﹤0.01%
11,200
-3,900
-26% -$34.1K
CVM icon
333
CEL-SCI Corp
CVM
$20.3M
$109K ﹤0.01%
348
-302
-46% -$88.1K
PR
334
Permian Resources
PR
$17.8B
$109K ﹤0.01%
+16,120
New +$87.9K
LOGC
335
CALL
DELISTED
ContextLogic
LOGC
$109K ﹤0.01%
+727
New +$181K
HYFT
336
PUT
MindWalk Holdings
HYFT
$60.6M
$108K ﹤0.01%
+17,500
New +$119K
MMAT
337
DELISTED
Meta Materials Inc. Common Stock
MMAT
$108K ﹤0.01%
222
+117
+111% +$51K
BCTX
338
Briacell Therapeutics
BCTX
$29.9M
$107K ﹤0.01%
+91
New +$83.7K
BMRA icon
339
CALL
Biomerica
BMRA
$4.6M
$107K ﹤0.01%
+2,363
New +$77.7K
CHRN
340
CALL
ChronoScale Holdings
CHRN
$3.2B
$107K ﹤0.01%
+1,720
New +$122K
ETON icon
341
Eton Pharmaceutcials
ETON
$1.27B
$107K ﹤0.01%
+20,829
New +$108K
SENS icon
342
Senseonics Holdings Inc
SENS
$263M
$107K ﹤0.01%
1,634
-49
-3% -$3.33K
VVOS icon
343
CALL
Vivos Therapeutics
VVOS
$5.7M
$107K ﹤0.01%
+1,104
New +$116K
ICPT
344
CALL
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
$106K ﹤0.01%
+6,500
New +$104K
CLOV icon
345
Clover Health Investments
CLOV
$2.2B
$104K ﹤0.01%
13,205
-27,040
-67% -$231K
CYCN icon
346
CALL
Cyclerion Therapeutics
CYCN
$14.9M
$104K ﹤0.01%
+2,000
New +$131K
SB icon
347
Safe Bulkers
SB
$795M
$104K ﹤0.01%
+22,099
New +$85.3K
CMRX
348
DELISTED
Chimerix, Inc.
CMRX
$104K ﹤0.01%
+17,740
New +$122K
ASTR
349
PUT
DELISTED
Astra Space, Inc. Class A Common Stock
ASTR
$104K ﹤0.01%
+747
New +$114K
ICPT
350
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
$104K ﹤0.01%
+6,358
New +$102K

Similar funds

Belvedere Trading's Q3 2021 Portfolio in Review

As of Q3 2021, Belvedere Trading held 683 positions worth $3.82B, up 184% from $1.34B the previous quarter. Its ten largest holdings account for 93% of the portfolio.

Belvedere Trading deployed $2.44B of net new capital in Q3 2021, opening 348 new positions and adding to 67 existing holdings. Its largest new stake was State Street SPDR S&P 500 ETF Trust: 192,540 shares worth $86.1M.

By sector, the portfolio is most concentrated in Technology at 4.2% of assets, down from 7.6% a quarter earlier, followed by Consumer Discretionary and Healthcare.

On the sell side, the largest reduction was Amazon, an estimated $30.5M trimmed.

  • Belvedere Trading's largest Q3 2021 buy was State Street SPDR S&P 500 ETF Trust: 192,540 shares worth $86.1M.
  • Belvedere Trading added most to Apple in Q3 2021, an estimated $57.7M increase.
  • Belvedere Trading's biggest Q3 2021 reduction was Amazon, cutting an estimated $30.5M.
  • Belvedere Trading fully exited Tesla in Q3 2021, selling an estimated $12.5M.
  • Belvedere Trading's ten largest holdings make up 93% of its $3.82B portfolio in Q3 2021.
  • Belvedere Trading opened 348 new positions and closed 206 in Q3 2021.
  • Belvedere Trading's portfolio value rose 184% quarter-over-quarter to $3.82B.

Based on Belvedere Trading's 13F filing for Q3 2021, filed 19 Oct 2021.